These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30182841)

  • 1. Lithium - Pharmacological and Toxicological Aspects: The Current State of the Art.
    Medić B; Stojanović M; Stimec BV; Divac N; Vujović KS; Stojanović R; Čolović M; Krstić D; Prostran M
    Curr Med Chem; 2020; 27(3):337-351. PubMed ID: 30182841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is impulsivity in part a lithium deficiency state?
    Giotakos O
    Psychiatriki; 2018; 29(3):264-270. PubMed ID: 30605431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Gould TD; Manji HK
    Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.
    de Sousa RT; Zanetti MV; Talib LL; Serpa MH; Chaim TM; Carvalho AF; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
    J Psychiatr Res; 2015 Mar; 62():78-83. PubMed ID: 25691093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of lithium action: state of the art, ten years later.
    Shaldubina A; Agam G; Belmaker RH
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):855-66. PubMed ID: 11383981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.
    McLean CK; Narayan S; Lin SY; Rai N; Chung Y; Hipolito MS; Cascella NG; Nurnberger JI; Ishizuka K; Sawa AS; Nwulia EA
    Transl Psychiatry; 2018 Apr; 8(1):81. PubMed ID: 29666369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium - therapeutic tool endowed with multiple beneficiary effects caused by multiple mechanisms.
    Vosahlikova M; Svoboda P
    Acta Neurobiol Exp (Wars); 2016; 76(1):1-19. PubMed ID: 27102914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
    Marmol F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological agents under research for the maintenance treatment in bipolar disorder.
    Dimitrakopoulos S; Konstantakopoulos G
    Psychiatriki; 2015; 26(3):169-80. PubMed ID: 26480221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current aspects of valproate in bipolar disorder.
    Lennkh C; Simhandl C
    Int Clin Psychopharmacol; 2000 Jan; 15(1):1-11. PubMed ID: 10836280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lithium in the treatment of acute depression].
    Adli M; Bschor T; Canata B; Döpfmer S; Bauer M
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10):435-41. PubMed ID: 9825248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
    Won E; Kim YK
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziskind-Somerfeld research Award. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders.
    Avissar S; Schreiber G
    Biol Psychiatry; 1992 Mar; 31(5):435-59. PubMed ID: 1581423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium interacts with cardiac remodeling: the fundamental value in the pharmacotherapy of bipolar disorder.
    Chen PH; Chao TF; Kao YH; Chen YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():208-214. PubMed ID: 30053574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.
    Li X; Friedman AB; Zhu W; Wang L; Boswell S; May RS; Davis LL; Jope RS
    Biol Psychiatry; 2007 Jan; 61(2):216-22. PubMed ID: 16806104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of lithium effects on brain and blood.
    Young W
    Cell Transplant; 2009; 18(9):951-75. PubMed ID: 19523343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.